{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:48:30Z","timestamp":1779270510434,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:00:00Z","timestamp":1540771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12874-018-0577-8","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T11:03:50Z","timestamp":1540811030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Examiners\u2019 influence on the measured active and passive extension deficit in finger joints affected by Dupuytren disease"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-5263","authenticated-orcid":false,"given":"Jesper","family":"Nordenskj\u00f6ld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stina","family":"Brod\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isam","family":"Atroshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,29]]},"reference":[{"issue":"3","key":"577_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.prs.0000438455.37604.0f","volume":"133","author":"R Lanting","year":"2014","unstructured":"Lanting R, Broekstra DC, Werker PM, van den Heuvel ER. A systematic review and meta-analysis on the prevalence of Dupuytren disease in the general population of Western countries. Plast Reconstr Surg. 2014;133(3):593\u2013603.","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"577_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/PRS.0b013e3182958a33","volume":"132","author":"R Lanting","year":"2013","unstructured":"Lanting R, van den Heuvel ER, Westerink B, Werker PM. Prevalence of Dupuytren disease in the Netherlands. Plast Reconstr Surg. 2013;132(2):394\u2013403.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"577_CR3","first-page":"316","volume":"76","author":"I Degreef","year":"2010","unstructured":"Degreef I, De Smet L. A high prevalence of Dupuytren\u2019s disease in Flanders. Acta Orthop Belg. 2010;76(3):316\u201320.","journal-title":"Acta Orthop Belg"},{"key":"577_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2474-14-131","volume":"14","author":"C Ball","year":"2013","unstructured":"Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013;14:131.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"577_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1753193416687914","volume":"42","author":"J Nordenskjold","year":"2017","unstructured":"Nordenskjold J, Englund M, Zhou C, Atroshi I. Prevalence and incidence of doctor-diagnosed Dupuytren\u2019s disease: a population-based study. J Hand Surg Eur Vol. 2017;42(7):673\u20137.","journal-title":"J Hand Surg Eur Vol"},{"issue":"5","key":"577_CR6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jhsa.2011.03.002","volume":"36","author":"SS Desai","year":"2011","unstructured":"Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011;36(5):936\u201342.","journal-title":"J Hand Surg Am."},{"issue":"3","key":"577_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/ijcp.12106","volume":"67","author":"J Dias","year":"2013","unstructured":"Dias J, Bainbridge C, Leclercq C, Gerber RA, Guerin D, Cappelleri JC, et al. Surgical management of Dupuytren\u2019s contracture in Europe: regional analysis of a surgeon survey and patient chart review. Int J Clin Pract. 2013;67(3):271\u201381.","journal-title":"Int J Clin Pract"},{"issue":"10","key":"577_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1056\/NEJMoa0810866","volume":"361","author":"LC Hurst","year":"2009","unstructured":"Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture. New Engl J Med. 2009;361(10):968\u201379.","journal-title":"New Engl J Med"},{"issue":"8","key":"577_CR9","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","volume":"40","author":"CA Peimer","year":"2015","unstructured":"Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Lindau T. Dupuytren contracture recurrence following treatment with collagenase Clostridium Histolyticum (CORDLESS [collagenase option for reduction of Dupuytren long-term evaluation of safety study]): 5-year data. J Hand Surg Am. 2015;40(8):1597\u2013605.","journal-title":"J Hand Surg Am"},{"issue":"2","key":"577_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/PRS.0b013e31823aea95","volume":"129","author":"AL van Rijssen","year":"2012","unstructured":"van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren\u2019s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129(2):469\u201377.","journal-title":"Plast Reconstr Surg"},{"key":"577_CR11","first-page":"CD010143","volume":"12","author":"JN Rodrigues","year":"2015","unstructured":"Rodrigues JN, Becker GW, Ball C, Zhang W, Giele H, Hobby J, et al. Surgery for Dupuytren\u2019s contracture of the fingers. Cochrane Database Syst Rev. 2015;12:CD010143.","journal-title":"Cochrane Database Syst Rev"},{"key":"577_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12891-016-0884-3","volume":"17","author":"AL Pratt","year":"2016","unstructured":"Pratt AL, Ball C. What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice. BMC Musculoskelet Disord. 2016;17:20.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"577_CR13","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jhsa.2014.04.029","volume":"39","author":"C Engstrand","year":"2014","unstructured":"Engstrand C, Krevers B, Nylander G, Kvist J. Hand function and quality of life before and after fasciectomy for Dupuytren contracture. J Hand Surg Am. 2014;39(7):1333\u201343 e2.","journal-title":"J Hand Surg Am."},{"issue":"3","key":"577_CR14","doi-asserted-by":"publisher","first-page":"e012943","DOI":"10.1136\/bmjopen-2016-012943","volume":"7","author":"A Lauritzson","year":"2017","unstructured":"Lauritzson A, Atroshi I. Collagenase injections for Dupuytren\u2019s disease: prospective cohort study assessing 2-year treatment effect durability. BMJ Open. 2017;7(3):e012943.","journal-title":"BMJ Open"},{"key":"577_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2474-12-136","volume":"12","author":"C Jerosch-Herold","year":"2011","unstructured":"Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D, Barrett E, Vaughan SP. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren\u2019s contracture: a pragmatic, multi-Centre, randomised controlled trial. BMC Musculoskelet Disord. 2011;12:136.","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"577_CR16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5014\/ajot.2012.001925","volume":"66","author":"C Engstrand","year":"2012","unstructured":"Engstrand C, Krevers B, Kvist J. Interrater reliability in finger joint goniometer measurement in Dupuytren\u2019s disease. Am J Occup Ther. 2012;66(1):98\u2013103.","journal-title":"Am J Occup Ther"},{"issue":"4","key":"577_CR17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.math.2015.01.010","volume":"20","author":"DC Broekstra","year":"2015","unstructured":"Broekstra DC, Lanting R, Werker PM, van den Heuvel ER. Intra- and inter-observer agreement on diagnosis of Dupuytren disease, measurements of severity of contracture, and disease extent. Man Ther. 2015;20(4):580\u20136.","journal-title":"Man Ther"},{"key":"577_CR18","first-page":"169","volume-title":"Rehabilitation of the hand and upper extremity","author":"CA Cambridge-Keeling","year":"2002","unstructured":"Cambridge-Keeling CA. Range-of-motion measurement of the hand. In: Mackin EJ, Callahan AD, Skirven TM, Schneider LH, Osterman AL, editors. Rehabilitation of the hand and upper extremity. St. Louis: The CV Mosby Company; 2002. p. 169\u201381."},{"issue":"2","key":"577_CR19","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/1753193414529074","volume":"40","author":"JN Rodrigues","year":"2015","unstructured":"Rodrigues JN, Zhang W, Scammell BE, Davis TR. Dynamism in Dupuytren\u2019s contractures. J Hand Surg Eur Vol. 2015;40(2):166\u201370.","journal-title":"J Hand Surg Eur Vol"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-018-0577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12874-018-0577-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-018-0577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T20:09:32Z","timestamp":1572293372000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-018-0577-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1186\/s12874-018-0577-8","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"22 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Regional Ethical Review Board in Lund, Sweden, waived the need for ethics approval (DNR 2013\/656). The study was conducted in accordance with the Helsinki Declaration of 1975 as revised in 2000. An oral and written consent to participate was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient in Fig.\u00a0 provided oral and written consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IA was a member of an expert group on Dupuytren disease for Pfizer in 2012 and participated in meetings organized by Sobi. JN and SB have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"120"}}